STAT+: A leading AI researcher calls for standards to ensure equity and fairness
A top researcher at the Massachusetts Institute of Technology on Thursday said that artificial intelligence…
Category: Boston
STAT Plus: The health tech tracker for the fourth quarter: 14 pivotal industry events to watch
Welcome to STAT’s Health Tech Tracker, a ledger of all the major data readouts, product…
Here come the tortoises: In the race for a Covid-19 vaccine, slow starters could still win out
The race is not always to the swift, as the cocky hare learned in Aesop’s…
STAT Plus: Teladoc’s tussle with Amwell raises questions about defining property rights in digital health
The field of health tech is facing a big question: Can it establish strong patent…
STAT Plus: Amwell rides IPO wave with expanded stock sale
Taking advantage of a pickup in demand for new stocks, American Well Corp. expanded its…
STAT Plus: Patent board delivers blow to University of California over its CRISPR invention claims
Making a key ruling in a long-running battle over lucrative patent rights, a government patent…
STAT Plus: Casma Therapeutics raises another $50 million to target muscular dystrophy
Casma Therapeutics, a Cambridge biotech trying to develop new medicines based on discoveries about how…
STAT Plus: Korro Bio raises $90 million to fix mutations that cause diseases
Korro Bio, a Cambridge biotechnology firm, said Thursday it has raised more than $90 million…
STAT Plus: Oncorus and three other startups got venture funding a year ago. Did it help them do what they said it would?
Most biotech startups are free to tell the world as little or as much as…
STAT Plus: Biofourmis raises $100 million for remote patient monitoring tools
Biofourmis, a Boston startup that makes technology to remotely monitor patients with chronic conditions and…
Experimental drug for ALS, dreamed up in a dorm room, offers patients glimmer of hope
An experimental drug for amyotrophic lateral sclerosis, or Lou Gehrig’s disease, slowed the neurological decline…
Immigration status, housing, and food-service work explain Covid-19’s burden on Latinos
A new analysis of one state’s Covid-19 data lays bare some of the reasons behind…
STAT Plus: Foundation Medicine wins FDA approval for first liquid biopsy able to detect multiple cancers
The Food and Drug Administration on Wednesday approved the first comprehensive “liquid biopsy” platform that…
Scientists create a synthetic lining for the intestine to make delivering drugs easier
Scientists have created a synthetic small intestinal lining designed to treat certain digestive diseases or…
STAT Plus: Telehealth company Amwell files to sell shares to public, Google
American Well Corp., a Boston telehealth company known as Amwell, said it plans to sell…
STAT Plus: ‘We’re going to keep going’: A new clinical trial for ALS gives patients hope
As a cardiologist, Dr. Marc Litt has plenty of arrows in his quiver for patients…
STAT Plus: 4 questions for neurology startups as venture investors pour millions into the field
As pharmaceutical companies stepped back from developing new drugs for neurological conditions, venture capitalists took…
STAT Plus: Hospital president wrote opinion piece critical of drug pricing efforts, but didn’t disclose role on Moderna board
Dr. Elizabeth Nabel, president of Brigham and Women’s Hospital, earlier this year criticized efforts to…
The FDA accepted Biogen’s Alzheimer’s drug submission. Next up, a highly anticipated outside expert review
The Food and Drug Administration has agreed to review a marketing application submitted by Biogen…
STAT Plus: Biogen strikes $1 billion deal with Denali to advance Parkinson’s drug based on approach that was nearly abandoned
Biogen said Thursday it will pay more than $1 billion to the biotech firm Denali…
STAT Plus: Prominent hospital president resigns from Moderna board after conflict of interest questions raised
Dr. Elizabeth Nabel, president of Brigham and Women’s Hospital, said Thursday she was resigning from…
STAT Plus: Coles-led Cerevel Therapeutics to raise $445 million to develop brain drugs with fewer side effects
Cerevel Therapeutics, a Boston neuroscience company spun out from Pfizer in 2018 and led by…
STAT Plus: A test you can breathe in: Scientists are developing synthetic biosensors to monitor lung disease
Imagine inhaling a sensor that could monitor lung disease patients’ response to therapy, emitting a…
STAT Plus: Ruling threatens to upend patents on Moderna’s Covid-19 vaccine
Moderna, racing to develop a vaccine for Covid-19, lost a key patent decision Thursday, one…
STAT Plus: ‘Inactive’ drug ingredients are not always inactive, study finds
What’s in that pill you just swallowed? The label on the bottle lists the drug’s…
STAT Plus: Among biotech venture capital firms, Flagship Pioneering got the best single-fund returns
A fund launched in 2012 by the biotech venture capital firm Flagship Pioneering is on…
STAT Plus: Hospitals deploy AI to send patients home earlier — and keep them there
Beth Israel Deaconess Medical Center has a problem familiar to many hospitals: Too many patients…
STAT Plus: Blueprint Medicines partners with Roche to develop and sell genetically targeted cancer drug
Blueprint Medicines is partnering with Roche to develop and market a cancer drug near approval…
STAT Plus: Relay Therapeutics, focused on solid tumors, seeks to raise $250M in IPO
Relay Therapeutics, a Cambridge, Mass.-biotech focusing on cancer treatments, plans to raise $250 million when…
.jpg)
STAT Plus: A new tool aims to help patients sort through 200 mental health apps — and counting
There are nearly 20,000 mental health apps that will do everything from tracking a person’s…
Gene-editing discovery could point the way toward a ‘holy grail’: cures for mitochondrial diseases
Biologist David Liu was in the middle of his morning commute to the Broad Institute…
In a new hospital ranking, doing good counts nearly as much as doing well
You won’t find the usual suspects like Massachusetts General Hospital or the Mayo Clinic at…
STAT Plus: After years of feuds, Vertex and the U.K. government reach a deal over cystic fibrosis medicines
U.K. officials and Vertex Pharmaceuticals (VRTX) have finally put to rest a years-long battle over…
STAT Plus: Federal prosecutors allege Regeneron used a charity to pay kickbacks to Medicare patients
Federal officials on Wednesday alleged that Regeneron Pharmaceuticals (REGN) donated tens of millions of dollars…
STAT Plus: Can a prescription video game actually make money? Akili is about to find out
Akili Interactive Labs proved last week that it could convince the Food and Drug Administration…
STAT Plus: A ‘semi-wartime’ effort: Thermo Fisher COO on adapting the business to a Covid-19 world
Way back in January, Thermo Fisher Scientific (TMO), the world’s largest maker of scientific tools,…
STAT Plus: New findings about little-studied cellular compartments could help make chemo more effective
Getting the right drug to the right place at the right time has been the…
STAT Plus: Court invalidates Biogen’s patent on blockbuster multiple sclerosis drug
Shares of Biogen fell Thursday after a federal court judge ruled in favor of generic…
‘We have a job to do’: Cancer patients and their doctors carry on with clinical trials during Covid-19
Cancer isn’t waiting for Covid-19 to go away. Neither is Karen Howley. Diagnosed two years…
STAT Plus: Momenta Pharma drug improves symptoms in patients with myasthenia gravis
Momenta Pharmaceuticals reported Monday that in a mid-stage clinical trial, an experimental medicine significantly improved…
STAT Plus: New data in sickle cell show biotech companies tackling disease in novel ways
Sickle cell disease features prominently at this year’s virtual meeting of the European Hematology Association,…
STAT Plus: Verve, raising another $63 million, seeks to advance gene-editing treatment for heart disease
Verve Therapeutics, a Cambridge biotech that wants to use gene-editing to lower cholesterol, said Thursday…
The novel coronavirus attacks the lungs. A biotech company sees a common enzyme as key to protecting them
When a person is infected with the novel coronavirus, the deadliest symptoms often show up…
STAT Plus: Sarepta’s gene therapy for limb-girdle disease shows improved muscle function after one year
Sarepta Therapeutics said Monday that three children born with a rare muscle-wasting disease called limb-girdle…
STAT Plus: In a first for RNA-modifying drugs, AstraZeneca partners with startup Accent Therapeutics
Drug giant AstraZeneca is moving deeper into RNA-based therapies with a new partnership with the…
STAT Plus: Recapping ASCO 2020, talking cancer therapy combinations, and looking to the future
Before it even started, ASCO 2020 was one for the books. Held virtually for the…
She’s spent decades caring for dying patients. When her mom’s time came, Covid-19 kept them apart
When Sharon Levine picked up, the person on the other end was sobbing. It was…
Wastewater testing gains support as an early warning system for Covid-19 cases
What only a month ago had been merely an intriguing laboratory finding about analyzing wastewater…
A biotech company tries to retrofit a lung drug to prevent Covid-19’s after effects
As the world scrambles to find antiviral treatments and vaccines for the novel coronavirus, some…
STAT Plus: Vertex angers U.K. cystic fibrosis patients with a delay in submitting data for its newest therapy
Vertex Pharmaceuticals (VRTX) has sparked a new round of anger among cystic fibrosis patients in…